Cart is empty New cancer drugs are being launched rapidly before their long-term effectiveness for patients can be evaluated. Several years later, most of them still lack scientific evidence for increasing life expectancy or improving quality of life, a study at the University of Gothenburg has shown.
Leave A Comment